PubHawk
May 2021 PMID 33770576

SARS-CoV-2 vaccines for cancer patients: a call to action.

Chiara Corti, Edoardo Crimini, Paolo Tarantino, Gabriella Pravettoni, Alexander M M Eggermont, Suzette Delaloge, Giuseppe Curigliano

Full text PDF Download social card

Mentions

6
Peak: 3 in Mar 2021
across 3 sources since Mar 2021

Extended reach

1,820
potential audience

Total likes

18

Video views

1,490

Mentions per month

Mar 2021

All 3 dated mentions so far are from Mar 2021.

Where it's discussed

  • News3 articles
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Posts frequently express support and emphasize the need for prioritizing cancer patients, using words like 'crucial' and 'urgent,' which reflect strong agreement. The tone is proactive, with comments advocating for better research and monitoring, indicating both high interest and moderate engagement in translating findings into practice.

AgreementModerate agreement

Most discussions align with the article's emphasis on the importance of vaccinating cancer patients and underline its call to action.

InterestHigh interest

Posts demonstrate high interest by highlighting the significance of the topic and sharing enthusiasm for vaccination efforts.

EngagementModerate engagement

Several posts delve into the implications and advocate for more inclusive data collection, showing moderate engagement.

ImpactModerate impact

The discussions indicate a recognition of the article’s potential influence on policy and clinical practice.

Abstract in brief

  • COVID-19 has severely impacted global health, with over 96 million cases, and vaccines are seen as crucial to restoring normalcy, especially for high-risk groups like cancer patients.
  • Cancer patients are often underrepresented in clinical trials for COVID-19 vaccines, so there is a call for better data collection and monitoring to ensure vaccine safety and effectiveness in this group.
  • Experts recommend prioritizing cancer patients for vaccination, based on evidence suggesting benefits outweigh risks, with healthcare providers making individualized decisions and implementing registries to track outcomes.
Read the full abstract

Top posts

Most liked on X and Bluesky
NFTdose
@PaperbirdsH · X

New article: SARS-CoV-2 vaccines for cancer patients: a call to action https://t.co/FuH6fbumQk #coronavirus #COVID19 #2019ncov https://t.co/yMjKkOHnyS

Mar 27, 2021 · 301 followers View post →

All mentions

NFTdose
@PaperbirdsH · X

New article: SARS-CoV-2 vaccines for cancer patients: a call to action https://t.co/FuH6fbumQk #coronavirus #COVID19 #2019ncov https://t.co/yMjKkOHnyS

Mar 27, 2021 · 301 followers View post →
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in ...
News

SARS-CoV-2 vaccines for cancer patients: a call to action. Eur J Cancer Oxf Engl 1990 2021;. 148:316e27. https://doi.org/10.1016/j.ejca.2021.01.046.

Dec 14, 2025 View →
Cavanna 2021 | PDF | Vaccines | Clinical Trial
News

doi: 10.1016/j.ejca.2021.01.046. 37. Barrière J, et al. Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with ...

Dec 14, 2025 View →
Amatu 2022 | PDF | Chemotherapy | Cancer
News

https://doi.org/10.1016/j.ejca.2021.01.046. ... The study was funded by Fondazione Oncologia the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; Niguarda and ...

Dec 14, 2025 View →